VA2
General Information
DRACP ID DRACP03525
Peptide Name VA2
Sequence KAXWKXVKXAK
Sequence Length 11
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial; Antiparasitic; Antifungal
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Acetylation
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C46H73N13O6
Absent amino acids CDEFGHILMNPQRSTY
Common amino acids K
Mass 141272
Pl 11.28
Basic residues 4
Acidic residues 0
Hydrophobic residues 4
Net charge 4
Boman Index -1221
Hydrophobicity -79.09
Aliphatic Index 44.55
Half Life
/
Extinction Coefficient cystines 5500
Absorbance 280nm 550
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 23876294
Title Mechanism of action of novel Synthetic peptide dodecapeptides against Candida albicans
Doi Not available
Year 2013
Literature 2
Pubmed ID 22118799
Title In vitro antibacterial and antimalarial activity of dehydrophenylalanine-containing undecapeptides alone and in combination with drugs
Doi Not available
Year 2012
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID 6283